Shire Wins Adderall Suit While Loser Gets Sanction Request

Law360, Boston (March 22, 2018, 7:42 PM EDT) -- Shire PLC prevailed on patent claims Thursday over a small pharmaceutical company that withheld data until midtrial showing how closely its generic product resembled hit hyperactivity treatment Adderall XR, misconduct that led a Massachusetts federal judge to take the unusual action of asking regulators to sanction the company.

U.S. District Judge William G. Young ruled in favor of Shire after a bench trial that included a five-month break last year for the parties to evaluate corrected drug tests that defunct manufacturer Abhai LLC belatedly submitted.

The judge ruled that Abhai's unnamed generic drug infringed two patents on a coating on amphetamine...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!